In patients with type 2 diabetes mellitus or metabolic syndrome, neutralization of circulating TNF-α does not improve insulin sensitivity [18] because the elevated TNF-α levels are a homeostatic response to maintain cytoplasmic glycogen in myocytes, not driven by inflammation. The gene discussed is TNF; the disease is metabolic syndrome.